Первый Санкт-Петербургский государственный медицинский университет имени И. П. Павлова — федеральное государственное бюджетное образовательное учреждение высшего образования Министерства здравоохранения Российской Федерации. До сегодняшнего дня вуз сменил несколько названий: Женский медицинский институт.

During the past decade, SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Kowa Research Europe" with 3 trials sponsored and "Novartis" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are "Dyslipidemia" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" in a lesser frequency.

Most popular intervention types in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are "Drug" (20 trials), "Behavioral" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Atezolizumab" (3 trials), "Diet" (3 trials), "Exercise" (3 trials) and "Pitavastatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF" are 20 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF has several departments that took part in Clinical trials: "RM Gorbacheva Research Institute" - 10 trials